Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -16.116% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a Cc1oc(-c2cccc(Cl)c2)nc1CS(=O)(=O)CC(=O)NC1CC1
b CCOc1ccccc1/C=C(/NC(=O)c1ccccc1)C(=O)NC(C)c1ccccc1
c CC1=NCC(C)c2c1[nH]c1ccccc21
Answer: b. CCOc1ccccc1/C=C(/NC(=O)c1ccccc1)C(=O)NC(C)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccccc1/C=C(/NC(=O)c1ccccc1)C(=O)NC(C)c1ccccc1
CCOc1ccccc1/C=C(/NC(=O)c1ccccc1)C(=O)NC(C)c1ccccc1
N-[(E)-1-(2-ethoxyphenyl)-3-oxo-3-(1-phenylethylamino)prop-1-en-2-yl]benzamide